磁共振成像在前列腺局灶腺体消融候选者中定位近尿道前列腺癌的效用
单中心分析67例接受MRI、靶向活检和根治性前列腺切除术的局灶腺体消融候选者,全 mount 病理显示48例(72%)肿瘤距尿道5 mm以内。MRI识别距尿道5 mm内癌的敏感度为77%(65%-89%),特异度为63%(42%-89%),阳性预测值84%,阴性预测值52%。结论认为相当比例候选者存在近尿道癌,MRI敏感度77%可用于改进患者选择。
要点
- 67例局灶消融候选者中48例(72%)全mount病理显示癌距尿道5 mm以内。
- MRI识别距尿道5 mm内癌的敏感度77%(65%-89%),特异度63%(42%-89%)。
- MRI阳性预测值84%,阴性预测值52%,与全mount病理一致49/67例(73%)。
核心结论
- 相当数量局灶腺体消融候选者存在近尿道癌,可能成为野内复发的重要来源。
- MRI识别这些病变的敏感度为77%,可用于进一步改进局灶腺体消融的患者选择。
研究设计与样本
- 单中心分析2012年7月至2021年4月接受MRI、靶向活检和根治性前列腺切除术的男性。
- 识别局灶腺体消融候选者,评估MRI识别距前列腺尿道5 mm内癌的能力,以全mount病理为确认标准。
- 采用多因素回归分析全mount病理显示癌距尿道5 mm以内的相关特征。
主要发现
- 67例中48例(72%)全mount病理显示肿瘤距尿道5 mm以内。
- MRI与全mount病理一致49/67例(73%)。
- MRI识别距尿道5 mm内癌的敏感度77%(65%-89%),特异度63%(42%-89%)。
- 阳性预测值84%(范围73%-95%),阴性预测值52%(32%-73%)。
- 校正分析中,PSA密度和前列腺影像报告和数据系统与癌近尿道无显著关联。
关键数值与推荐
- MRI识别距尿道5 mm内癌的敏感度77%(65%-89%),特异度63%(42%-89%)。
- 阳性预测值84%(范围73%-95%),阴性预测值52%(32%-73%)。
临床怎么用
- 原文结论认为MRI识别近尿道癌的敏感度为77%,可用于进一步改进局灶腺体消融的患者选择。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Given that treatment near the urethra is often limited to reduce side effects, in this study we aim to determine whether prostate MRI can accurately identify the distance of prostate cancer to the urethra in a cohort of men who were potential candidates for focal gland ablation. MATERIALS AND METHODS: A single-institution analysis was performed of men who underwent MRI, targeted biopsy, and radical prostatectomy from July 2012 to April 2021. Men who were candidates for focal gland ablation were identified. The ability of MRI to identify prostate cancer within 5 mm of the prostatic urethra as confirmed on whole-mount pathology was assessed. Multivariate regression was utilized to determine characteristics associated with prostate cancer within 5 mm of the urethra on whole-mount pathology. RESULTS: In 48 out of 67 men (72%), the tumor was within 5 mm of the urethra on whole-mount pathology. MRI was concordant with whole-mount pathology in 49 out of 67 men (73%). The sensitivity of MRI for identifying cancer within 5 mm of the urethra was 77% (65%-89%) and the specificity was 63% (42%-89%). The positive predictive value was 84% (range 73%-95%) and negative predictive value was 52% (32%-73%). In adjusted analysis, PSA density and Prostate Imaging-Reporting and Data System were not significantly associated with having prostate cancer within close proximity of the urethra. CONCLUSIONS: A significant number of men who are potential candidates for focal gland ablation have cancer within close proximity to the urethra that could serve as a significant source of in-field recurrence. The sensitivity of MRI for identifying these lesions is 77% and can be used to further improve patient selection for focal gland ablation.
引用
- Patel N, Hughes A, Zhang JH, et al. Utility of Magnetic Resonance Imaging for Localizing Prostate Cancer Near the Urethra in Men Who Are Candidates for Focal Gland Ablation. J Urol. 2023. PMID: 36753630. doi:10.1097/JU.0000000000003197
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。